- Preview Available
- Scholarly Journal
Addressing HCV Elimination Barriers in Italy: Healthcare Resource Utilization and Cost Impact Using 8 Weeks’ Glecaprevir/Pibrentasvir Therapy
Infectious Diseases and Therapy; Philadelphia Vol. 10, Iss. 2, (Jun 2021): 763-774.
DOI:10.1007/s40121-021-00410-0
This is a limited preview of the full PDF
Try and log in through your library or institution to see if they have access.